Market News & Trends
QRxPharma Announces NDA Filing
QRxPharma Limited recently announced initiation of the NDA approval process for MoxDuo IR with the US FDA. This NDA submission sets the stage for the…
Zogenix & DURECT Announce Agreement for Antipsychotic Product Candidate
Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, and DURECT Corporation, a specialty pharmaceutical…
Infinity Expands Development Program for Oral Smoothened Antagonist Targeting Hedgehog Pathway
Infinity Pharmaceuticals, Inc. recently announced it is expanding its clinical development program for IPI-926, a novel, oral small molecule that inhibits Smoothened, a key component…
ResearchDx & CompanDX Announce Strategic Partnership
ResearchDx, LLC recently announced a strategic partnership with CompanDX to offer a full capability to discover and deliver novel molecular diagnostic tests for clients in…
Unique Gel Capsule Structure Enables Co-Delivery of Different Types of Drugs
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The…
Zogenix Enters $30-Million Royalty Financing Agreement
Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, recently announced it has entered into…
Evotec & Roche to Jointly Develop Biomarkers in Oncology
Evotec AG and Roche recently announced a collaboration in novel protein activity based biomarkers for Roche's oncology drugs under development. Evotec AG will employ its…
Gateway Analytical Registers With US FDA
Gateway Analytical showed confidence in its quality system, a collection of policies, procedures, plans, and supporting infrastructure documenting control over all activities, for pharmaceutical analysis…
7/12/2011
Evotec & Roche to Jointly Develop Biomarkers in Oncology Evotec AG and Roche recently announced a collaboration in novel protein activity based biomarkers for…
Alliqua Expands Patent Portfolio for Transdermal Drug Delivery Platform
Alliqua, Inc, an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, recently announced it has…
Evonik Degussa Provides Pharmaceutical Melt Extrusion Technology Services
Evonik Degussa Corporation recently announced the purchase of a Leistritz Nano 16-mm (TSE) Twin Screw Extruder to serve the growing number of customers using pharmaceutical…
Hovione & Particle Sciences Inc. Ink Deal to Speed Up Drug Solubilization Projects
Hovione and Particle Sciences Inc (PSI) recently announced a collaboration agreement under which they will pool their technologies together to significantly speed development projects targeting…
Oxygen Biotherapeutics Approved to Expand Trials for Traumatic Brain Injury
Oxygen Biotherapeutics, Inc recently announced it has received approval by the Drug Controller General of India to conduct its traumatic brain injury Phase IIb clinical…
Pulmatrix Shows iSPERSE Effectively Delivers Doses of Multi-Drug Formulations
Pulmatrix recently announced that data relating to the preclinical efficacy and multi-drug formulation and delivery capabilities of the company's novel iSPERSE inhaled dry powder drug…
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity
Tekmira Pharmaceuticals Corporation recently provided comments on presented data from a Phase I human clinical trial with ALN-VSP conducted by Alnylam Pharmaceuticals, Inc. ALN-VSP, an…
6/21/2011
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity Tekmira Pharmaceuticals Corporation recently provided comments on presented data from a…
Protea Announces Completion of Human Clinical Trial for New Biopharmaceutical
Protea Biosciences, a leading developer of new technology for pharmaceutical research, recently announced that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has…
Rhenovia Enters Strategic Alliance With Portmann Instruments
Rhenovia Pharma SAS, a biotechnology company specialized in the development and optimization of treatments for diseases of the central and peripheral nervous systems, recently announced…
3M Signs Development Agreement; Updates Phosphagenics Collaboration
3M Drug Delivery Systems and Radius Health, Inc. recently announced an agreement to collaborate on the development of a transdermal delivery option of BA058, Radius'…
Ashland to Acquire International Specialty Products
Ashland Inc. and International Specialty Products Inc. (ISP) recently announced that Ashland has agreed to acquire privately owned ISP, a global specialty chemical manufacturer of…
